Study Shows Safety of BioPharmX Topical Formulation
BioPharmX Corporation, a specialty pharmaceutical company, announced that research being presented at ASCB 2015 in San Diego shows its unique formulation of minocycline known as BPX-01 may offer a breakthrough in acne
This content is restricted to site members. If you are an existing user, please log in. New users may register below.